One page, thousands of outlets. See who else covered it.
Twenty years after his Nobel-winning discovery, doctors are using Yamanaka's cell-reprogramming breakthrough to treat real patients—and address aging itself.
We haven't written up this one. Time has the full story — the link below goes straight to it.
A Regeneron drug for an ultra-rare disease that causes bone to grow where it shouldn't won U.S. regulatory approval, capping a three-decade effort
Fifteen years after Rick Rypien's death, his brother says support for NHL players has improved. But youth leagues have a long way to go
The psychiatrist directs the longest study of human life. Here’s what he’s learned about the importance of social connection.
Rewinding cellular time could address disease and aging, says the Altos Labs co-founder.
Dr. Minter-Jordan wants to retire the idea that aging equals decline, and aims to rebuild policy around living longer and better.
